Complete remission of Crohn's disease after high-dose alpha-interferon treatment for malignant melanoma

被引：1
|
作者：
Ferre Aracil, Carlos [1 ]
Rodriguez de Santiago, Enrique [1 ]
Garcia Garcia de Paredesa, Ana [1 ]
Aguilera Castro, Lara [1 ]
Soria Rivas, Ainara [2 ]
Lopez SanRoman, Antonio [1 ]
机构：
[1] Hosp Univ Ramon y Cajal, Serv Gastroenterol, Madrid, Spain
[2] Hosp Univ Ramon y Cajal, Med Oncol Serv, Madrid, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2016年 / 39卷 / 06期
关键词：
INFLAMMATORY-BOWEL-DISEASE; INCREASED RISK; THERAPY;
D O I：
10.1016/j.gastrohep.2015.05.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：397 / 400
页数：4
相关论文
共 50 条
  • [31] Safety of high-dose corticosteroids in Crohn's disease flare
    Reactions Weekly, 1997, 647 (1) : 5 - 5
  • [32] Depression during low-dose interferon alpha treatment in patients with malignant melanoma
    Heinze, S.
    Roetzer, S.
    Volkenandt, M.
    Schaefer, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S382 - S382
  • [33] Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation
    Hasselblatt, P.
    Drognitz, K.
    Potthoff, K.
    Bertz, H.
    Kruis, W.
    Schmidt, C.
    Stallmach, A.
    Schmitt-Graeff, A.
    Finke, J.
    Kreisel, W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 725 - 735
  • [34] Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease
    Suzuki Y.
    Iida M.
    Ito H.
    Tachikawa N.
    Hibi T.
    Drugs in R&D, 2016, 16 (1) : 35 - 43
  • [35] HIGH-DOSE ALPHA-2-RECOMBINANT INTERFERON IN THE TREATMENT OF MALIGNANT LYMPHOPROLIFERATIVE DISEASES - A PILOT-STUDY
    OPAT, P
    DRBAL, J
    VYZULA, R
    NEOPLASMA, 1989, 36 (04) : 489 - 494
  • [36] A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma
    Amato, R
    Meyers, C
    Ellerhorst, J
    Finn, L
    Kilbourn, R
    Sella, A
    Logothetis, C
    ANNALS OF ONCOLOGY, 1995, 6 (09) : 911 - 914
  • [37] Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide
    Oliva-Hemker, MM
    Loeb, DM
    Abraham, SC
    Lederman, HM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 36 (05): : 639 - 643
  • [38] Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma
    Qazilbash, Muzaffar H.
    Saliba, Rima M.
    Aleman, Ana
    Lei, X.
    Weber, Donna
    Carrasco, Antonio
    Champlin, Richard E.
    Giralt, Sergio A.
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1360 - 1364
  • [39] Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy
    Auyeung, S. Freda
    Long, Qi
    Royster, Erica Bruce
    Murthy, Smitha
    McNutt, Marcia D.
    Lawson, David
    Miller, Andrew
    Manatunga, Amita
    Musselman, Dominique L.
    CLINICAL TRIALS, 2009, 6 (05) : 480 - 490
  • [40] LONG-TERM REMISSION OF CHRONIC HBEAG POSITIVE HEPATITIS-B AFTER ALPHA-INTERFERON TREATMENT
    TASSOPOULOS, NC
    PAPATHEODORIDIS, GV
    FRANGOU, E
    DELLADETSIMA, I
    ANGELOPOULOU, P
    KAPATAIS, A
    HATZAKIS, A
    HEPATOLOGY, 1994, 19 (04) : I132 - I132
12345